CISA would coordinate protection of biotechnology infrastructure

CISA would coordinate work to protect biotechnology and biomanufacturing infrastructure. The provisions cover biotechnology and biomanufacturing infrastructure, including its owners and operators. Special staff support and coordination apply where no federal agency is assigned to the sector. For infrastructure without a designated federal agency, CISA staff would provide technical help and outreach, and bring relevant agencies together when appropriate. Assessments would be coordinated with relevant information-sharing groups and industry associations.

The CISA Director would send Congress a work plan and reports on its progress and remaining protection gaps. The reports would go to the House Homeland Security Committee and the Senate Homeland Security and Governmental Affairs Committee. The work plan would identify stakeholders, explain outreach about existing critical infrastructure protections, plan for their representation in relevant groups, and set out a strategy update informed by stakeholder input. The work plan would be due within 45 days after enactment and include a strategy update by September 30, 2027. An implementation report would be due within one year after the work plan. A report on remaining gaps would be due by the earlier of two years after the work plan or the next specified evaluation and recommendation after enactment.